A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma

Figure 7

Survival analysis of HCC patients based on the risk score and several hypoxia-related genes. (a) Expression profiles of several hypoxia-related genes in high-risk and low-risk groups. (b–l) Two-factor survival analyses of risk score and immune checkpoint molecules including SLC2A1 (b), LDHA (c), ALDOA (d), ENO1 (e), VEGFA (f), ACOT7 (g), TPI1 (h), CDKN3 (i), MRPS17 (j), MIF (k), and NDRG1 (l).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)